Opioid Destruction Education for Postoperative Care

Overseen By Stacie J Ethington, MSN RN

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Nebraska

Must be taking: Opioids

Disqualifiers: Under 19, Opioid use prior

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

163 Participants Needed

Trial Summary

What is the purpose of this trial?

This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.

Research Team

Kristin R Daniel, PharmD

Principal Investigator

University of Nebraska

Eligibility Criteria

This trial is for adults who've had a total knee or hip replacement, are going home with an opioid prescription, and haven't used opioids before the surgery. It's not for those under 19 or anyone not prescribed opioids after discharge.

Inclusion Criteria

I am going home with painkillers after knee or hip replacement surgery.

Exclusion Criteria

Opioid medication use prior to surgery

I am under 19 years old.

I am not prescribed opioids for after I leave the hospital.

Treatment Details

Interventions

• Opioid destruction education

Trial Overview The study focuses on teaching patients about proper storage and destruction of opioid medications post-surgery. Participants will be followed up within 6-8 weeks to discuss their use, storage, and disposal of these pain meds.

Participant Groups

Group I: Intervention Experimental Treatment 1 Intervention

Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Surveys will be sent to group at 6-8 weeks post discharge.

Group II: Control Active Control 1 Intervention

Control group will receive current standard of care education and surveys at 6-8 weeks post discharge.

Who Is Running the Clinical Trial?

University of Nebraska

Lead Sponsor

Trials

563

Recruited

1,147,000+